These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21550933)

  • 1. [Tumor lysis syndrome in a patient with a renal carcinoma treated with sunitinib].
    Rodríguez-Reimúndes E; Perazzo F; Vilches AR
    Medicina (B Aires); 2011; 71(2):158-60. PubMed ID: 21550933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate.
    Nicholaou T; Wong R; Davis ID
    Lancet; 2007 Jun; 369(9577):1923-4. PubMed ID: 17560435
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal liver failure in a patient treated with sunitinib for renal cell carcinoma.
    Mermershtain W; Lazarev I; Shani-Shrem N; Ariad S
    Clin Genitourin Cancer; 2013 Mar; 11(1):70-2. PubMed ID: 23063577
    [No Abstract]   [Full Text] [Related]  

  • 4. Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma.
    Michels J; Lassau N; Gross-Goupil M; Massard C; Mejean A; Escudier B
    Invest New Drugs; 2010 Oct; 28(5):690-3. PubMed ID: 19547920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sunitinib and hypothyroidism.
    Wolter P; Dumez H; Schöffski P
    N Engl J Med; 2007 Apr; 356(15):1580; author reply 1580-1. PubMed ID: 17429091
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment with sunitinib and hypothyroidism--a case report and overview of literature].
    Kreze A; Stáhalová V; Zadrazilová A; Koskuba J; Kosák M
    Klin Onkol; 2009; 22(4):176-8. PubMed ID: 19731880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue with sunitinib-induced hypothyroidism.
    Senior K
    Lancet Oncol; 2007 Feb; 8(2):101. PubMed ID: 17288042
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe rhabdomyolysis during sunitinib treatment of metastatic renal cell carcinoma. A report of two cases.
    Ruggeri EM; Cecere FL; Moscetti L; Doni L; Padalino D; Di Costanzo F
    Ann Oncol; 2010 Sep; 21(9):1926-1927. PubMed ID: 20729535
    [No Abstract]   [Full Text] [Related]  

  • 9. Lower limbs erosions induced by sunitinib.
    Kluger N; Chapelle A; Jacot W; Guillot B
    Acta Derm Venereol; 2011 May; 91(3):360-1. PubMed ID: 21103845
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute cardiac failure after sunitinib.
    Machiels JP; Bletard N; Pirenne P; Jacquet L; Bonbled F; Duck L
    Ann Oncol; 2008 Mar; 19(3):597-9. PubMed ID: 18272908
    [No Abstract]   [Full Text] [Related]  

  • 11. Pazopanib outscores sunitinib on tolerability.
    Cancer Discov; 2014 Jan; 4(1):OF8. PubMed ID: 24402960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe exacerbation of Crohn's disease during sunitinib treatment.
    Boers-Sonderen MJ; Mulder SF; Nagtegaal ID; Jacobs JF; Wanten GJ; Hoentjen F; van Herpen CM
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):234-6. PubMed ID: 24025975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sunitinib-induced microangiopathic hemolytic anemia with fatal outcome.
    Talebi TN; Stefanovic A; Merchan J; Lian E; Silva O
    Am J Ther; 2012 Jul; 19(4):e143-5. PubMed ID: 21403468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal perforation after two years of treatment with sunitinib for metastatic kidney cancer.
    Bladé JS; Bourgouin S; Romeo É; Boudin L; de Jauréguiberry JP
    Presse Med; 2014 Nov; 43(11):1293-5. PubMed ID: 24999082
    [No Abstract]   [Full Text] [Related]  

  • 15. Palmar-plantar erythrodysesthesia secondary to sunitinib treatment resulting in necrotic foot syndrome aggravated by background diabetic vascular disease.
    Guenova E; Weber HO; Voykov B; Metzler G; Mitev V; Berneburg M; Hoetzenecker W; Röcken M
    Arch Dermatol; 2008 Aug; 144(8):1081-2. PubMed ID: 18711102
    [No Abstract]   [Full Text] [Related]  

  • 16. Sunitinib-induced thyrotoxicosis - a not so rare entity.
    Jazvić M; Prpić M; Jukić T; Murgić J; Jakšić B; Kust D; Prgomet A; Bolanča A; Kusić Z
    Anticancer Res; 2015 Jan; 35(1):481-5. PubMed ID: 25550591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Baeksgaard L; Sørensen JB
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home blood-pressure monitoring in patients receiving sunitinib.
    Azizi M; Chedid A; Oudard S
    N Engl J Med; 2008 Jan; 358(1):95-7. PubMed ID: 18172185
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversible posterior leukoencephalopathy syndrome following sunitinib therapy: a case report and review of the literature.
    Khan KH; Fenton A; Murtagh E; McAleer JJ; Clayton A
    Tumori; 2012; 98(5):139e-142e. PubMed ID: 23235770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pazopanib-related tumor lysis syndrome in metastatic clear cell renal cell carcinoma: a case report.
    van Kalleveen MW; Walraven M; Hendriks MP
    Invest New Drugs; 2018 Jun; 36(3):513-516. PubMed ID: 29464464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.